Leviorinil

Active substance

cetirizine dihydrochloride

Strenght and pharmaceutical forms

10 mg / ml oral drops, solution - 20 ml

ATC

R06AE07 - piperazine derivatives

Therapeutic Indications

Leviorinil is indicated in adults and paediatric patients 6 years of age and up for:
- nasal and ocular symptoms of seasonal and perennial allergic rhinitis;
- symptomatic treatment of chronic idiopathic urticaria.

Marketing Authorization Holder

Aesculapius Farmaceutici S.r.l.